These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37573499)

  • 1. The effect of toxoplasmosis on renal function in hemodialysis patients.
    Abood MA; Saheb EJ
    Ann Parasitol; 2022; 68(4):685-692. PubMed ID: 37573499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of C-reactive protein and ferritin in COVID-19 patients infected with Toxoplasma gondii.
    Ali MS; Saheb EJ
    Ann Parasitol; 2022; 68(1):47-54. PubMed ID: 35439407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Toxoplasma gondii antibodies in hemodialysis patients receiving long-term hemodialysis therapy in Turkey.
    Ocak S; Duran N; Eskiocak AF; Aytac H
    Saudi Med J; 2005 Sep; 26(9):1378-82. PubMed ID: 16155651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of Toxoplasma gondii among hemodialysis patients: A possible link to main T-lymphocyte subsets levels and dialysis adequacy.
    Salem DA; Hendawy SR; Nassar MK
    Acta Trop; 2023 Jan; 237():106703. PubMed ID: 36181878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.
    Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB
    BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology and Associated Risk Factors of Toxoplasma gondii in Hemodialysis Patients.
    Saadat F; Mahmoudi MR; Rajabi E; Roshan ZA; Shad BM; Karanis P
    Acta Parasitol; 2020 Dec; 65(4):906-912. PubMed ID: 32533419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV
    Rafati-Sajedi H; Majidi-Shad B; Jafari-Shakib R; Atrkar-Roshan Z; Mahmoudi MR; Rezvani SM
    Acta Parasitol; 2021 Dec; 66(4):1417-1423. PubMed ID: 34021879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodiagnosis and molecular validation of
    Arab-Mazar Z; Fallahi S; Yadegarynia D; Javadi Mamaghani A; Seyyed Tabaei SJ; Rajaeian S; Rahmati Roodsari S
    Parasitology; 2019 Nov; 146(13):1683-1689. PubMed ID: 31397237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, Mexico.
    Alvarado-Esquivel C; Liesenfeld O; Torres-Castorena A; Estrada-Martínez S; Urbina-Alvarez JD; Ramos-de la Rocha M; Márquez-Conde JA; Dubey JP
    J Parasitol; 2010 Jun; 96(3):505-8. PubMed ID: 20557194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of Toxoplasma gondii infection in drivers involved in road traffic accidents in the metropolitan area of Guadalajara, Jalisco, Mexico.
    Galván-Ramírez Mde L; Sánchez-Orozco LV; Rodríguez LR; Rodríguez S; Roig-Melo E; Troyo Sanromán R; Chiquete E; Armendáriz-Borunda J
    Parasit Vectors; 2013 Oct; 6(1):294. PubMed ID: 24499659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of Anti-
    Yürektürk Ş; Yılmaz H; Taş Cengiz Z
    Turkiye Parazitol Derg; 2023 Mar; 47(1):16-21. PubMed ID: 36872480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS AS- SOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA.
    Zaki WM; Hofdi RY; Shebiley AA; Saadi ZA; Ageel AH
    J Egypt Soc Parasitol; 2016 Dec; 46(3):467-474. PubMed ID: 30230742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Toxoplasma gondii Infection Among Β-Thalassemia Major Pediatric Population: Implications for Transfusion Transmissible Toxoplasmosis.
    El-Tantawy N; Darwish A; Eissa E
    Pediatr Infect Dis J; 2019 Mar; 38(3):236-240. PubMed ID: 29762364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation on
    Yun F; Hui-Fang L; Min-Yuan S
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Dec; 28(6):664-668. PubMed ID: 29469258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Toxoplasma gondii in Western Romania.
    Olariu TR; Petrescu C; Darabus G; Lighezan R; Mazilu O
    Infect Dis (Lond); 2015 Aug; 47(8):580-3. PubMed ID: 25851242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of
    Yousif WT
    Arch Razi Inst; 2022 Aug; 77(4):1491-1495. PubMed ID: 36883147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.
    Al-Adhroey AH; Mehrass AAO; Al-Shammakh AA; Ali AD; Akabat MYM; Al-Mekhlafi HM
    BMC Infect Dis; 2019 Dec; 19(1):1089. PubMed ID: 31888517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the toxoplasmosis seroprevalence in pregnant women and creating a diagnostic algorithm].
    Mumcuoglu I; Toyran A; Cetin F; Coskun FA; Baran I; Aksu N; Aksoy A
    Mikrobiyol Bul; 2014 Apr; 48(2):283-91. PubMed ID: 24819265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of
    Esenkaya Taşbent F; Beder D; Özdemir M; Doğan M; Feyzioğlu B
    Turkiye Parazitol Derg; 2022 Mar; 46(1):1-6. PubMed ID: 35232698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A four-year investigation of the seropositivity of Toxoplasma gondii in our hospital].
    Kuk S; Ozden M
    Turkiye Parazitol Derg; 2007; 31(1):1-3. PubMed ID: 17471402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.